Durvalumab vs Trazodone

Durvalumab vs Trazodone: Overview

This comparison examines the pharmacological differences between Durvalumab and Trazodone.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Trazodone: Serotonin antagonist and reuptake inhibitor (SARI).

Pharmacokinetics

Half-life: Durvalumab — 17 days; Trazodone — 5-9 hours.

Chemical Properties

Molecular Formula: Trazodone — C19H22ClN5O.

Molecular Weight: Trazodone — 371.8640 g/mol.

Type: Durvalumab — Antibody; Trazodone — Small molecule.